Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ICK-Breast: Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer

NCT05914961 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT05914961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05914961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ICK-Breast: Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2024
Completion date
April 30, 2035
Enrollment
225 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tnbc - triple-negative breast cancer